Biotech · Private company
Invivoscribe, Inc.
Track this companyFree. Adds Invivoscribe, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- IdentiClone Dx IGH (IC IGH Dx) AssayB-Cell Lymphoproliferative DisorderClinicalTrials.gov · fetched Nov 12, 2026
- IdentiClone Dx TRG AssayT-Cell Lymphoproliferative DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG AssayNOT_YET_RECRUITING · started Jun 2, 2025ClinicalTrials.gov NCT06876571 · fetched Nov 12, 2026
- The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical ResearchRECRUITING · started Mar 30, 2024ClinicalTrials.gov NCT06222164 · fetched Nov 12, 2026
- Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx IGH AssayCOMPLETED · started Jan 2, 2024ClinicalTrials.gov NCT06112301 · fetched Nov 12, 2026
- Minimal Residual Disease in Peripheral T-cell LymphomaCOMPLETED · started Jul 31, 2017ClinicalTrials.gov NCT03297697 · fetched Nov 12, 2026